NeuroPace Inc. (NPCE)
13.97
-0.27 (-1.90%)
At close: Jan 28, 2025, 2:09 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Net Income | -32.96M | -47.08M | -36.08M | -24.28M | -29.97M |
| Depreciation & Amortization | 1.60M | 2.99M | 296.00K | 312.00K | 421.00K |
| Stock-Based Compensation | 9.56M | 8.35M | 4.29M | 1.38M | 1.44M |
| Other Working Capital | 3.82M | -2.91M | -259.00K | -356.00K | 2.48M |
| Other Non-Cash Items | 4.58M | 3.67M | 1.07M | 2.86M | 4.02M |
| Deferred Income Tax | n/a | n/a | 5.48M | 187.00K | -944.00K |
| Change in Working Capital | -2.48M | -4.79M | 368.00K | -2.07M | 9.00K |
| Operating Cash Flow | -19.70M | -36.87M | -24.58M | -21.61M | -25.03M |
| Capital Expenditures | -173.00K | -603.00K | -384.00K | -62.00K | -468.00K |
| Acquisitions | n/a | n/a | n/a | 10.71M | 4.00K |
| Purchase of Investments | n/a | n/a | -85.01M | -17.00M | -18.02M |
| Sales Maturities Of Investments | 23.20M | 24.40M | n/a | 6.30M | 22.10M |
| Other Investing Acitivies | n/a | 24.40M | -85.01M | -10.71M | 4.09M |
| Investing Cash Flow | 23.03M | 23.80M | -85.40M | -10.77M | 3.62M |
| Debt Repayment | n/a | n/a | -4.09M | 24.46M | 21.33M |
| Common Stock Repurchased | -259.00K | -59.00K | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 239.00K | 490.00K | -2.47M | 62.24M | 42.00K |
| Financial Cash Flow | 8.13M | 490.00K | 102.53M | 55.01M | 21.37M |
| Net Cash Flow | 11.45M | -12.58M | -7.45M | 22.63M | -38.00K |
| Free Cash Flow | -19.87M | -37.47M | -24.96M | -21.67M | -25.49M |